A novel approach to Parkinson's disease treatment with a potentially dual-acting therapeutic agent that targets α-synuclein aggregation and neuron death

一种治疗帕金森病的新方法，采用一种可能具有双重作用的治疗药物，靶向α-突触核蛋白聚集和神经元死亡。